scholarly journals Vitamin D Supplements: Over-the-Counter Accessibility... It Is Safe?

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A231-A231
Author(s):  
Alegyari Figueroa-Cruz ◽  
Lisselle M Villarrubia-Ocasio ◽  
Luis N Madera-Marin ◽  
Yineli Ortiz-Torres ◽  
Francis Vazquez-Roura ◽  
...  

Abstract Calcium is the fifth most abundant element in earth and human body. It has multiple functions within our system such bone mineralization, neuromuscular excitability regulation, hemostasis, membrane transport, release of hormones and neurotransmitters, among others. For duodenal absorption of calcium, we need vitamin D, reason for which supplementation of both components is important to maintain adequate calcium homeostasis. However, it is entirely beneficial or can be harmful? As we know everything in excess has its consequences, as we describe below. 72 y/o male is brought to the ED after relative find him lethargic, she reports noticing generalized weakness that has been progressing over weeks, prominent in upper extremities with associated increased in urinary frequency. Patient past medical history is relevant for CAD, hypothyroidism, dyslipidemia, and DMT2. On physical examination patient is found hypoactive, but arousable to verbal stimuli, without distress, focal neurologic deficit, thyromegaly nor lymphadenopathy. Presents with Ca+: 18.8mg/dL (n:8.0–10.5mg/dL), that could explain patient clinical presentation for which workup for hypercalcemia is done finding PTH suppress: 14.57pg/mL (n:15-65pg/mL). Patient now with non-PTH related hypercalcemia is further evaluated and found with negative UPEP and SPEP ruling out multiple myeloma and PTH-rp <2.0pmol/L (negative). While etiology of severe hypercalcemia is being study, patient complications of it are being managed such as AKI stage 3 as he presents with Cr: 3.85mg/dL, BUN: 62.5, CrCl:18ml/min and GFR: 15ml/min. Aggressive IV hydration and bisphosphonate therapy failed to decrease calcium and renal function continues worsens, for which hemodialysis is required for calcium clearance. Patient then found with vitamin D25-OH levels: 210.4ng/mL (n:30-100ng/mL), upon questioning he reports taking multivitamins and supplements equivalent for a daily ingestion of 50,700IU of Vitamin D3 and 334mg of calcium carbonate. Patient calcium levels normalize after dialysis but develops renal failure for which he has to be discharged on permanent hemodialysis. Although prevalence is unknown, hypercalcemia due to vitamin D intoxication is relatively uncommon in comparison to hyperparathyroidism and malignancy. An exact dose intake that leads to intoxication has not yet being stablished but supplementation besides dosage is also dependent on duration of therapy. This case has a lot to teach us, starting with detrimental effects of hypercalcemia, follow by the consequences of lack of counseling and close follow-up of patient over-the-counter supplementation. As physicians we should inquire more about OTC medications and supplements our patients are taking not only for intoxication concerns, but also for drugs interactions. Counseling must be the cornerstone of our practice to avoid life changing consequences as in this case.

Author(s):  
Laura A. G. Armas ◽  
Philip Gregory ◽  
Ronald L. Horst

With the increased Institute of Medicine recommendation for vitamin D, more consumers are taking vitamin D from over-the-counter or prescription sources. The purpose of this study was to determine the content of commercially available, single-ingredient vitamin D supplements. Eleven commercially available dietary supplement calciferol products were purchased, repackaged, and analyzed for vitamin D content in a laboratory that was blinded to brand or manufacturer of the supplement. Vitamin D was extracted and isolated for analysis by a high-performance liquid chromatography method. Measured vitamin D content was compared with the stated label amount of vitamin D. The percentage of actual vitamin D contained in the supplements ranged from 82% and 119% of the stated label amount. Despite anecdotal reports of products with substantial content deviations from the labeled amount, no remarkable departures from labeled content were found in this set of vitamin D preparations.


JMS SKIMS ◽  
2011 ◽  
Vol 14 (2) ◽  
pp. 40-42
Author(s):  
Muzafar Maqsood Wani ◽  
Imtiaz Ahmed Wani

Major biologic function of activated vitamin D is to maintain normal blood levels of calcium and phosphorus, thus regulating bone mineralization. Research suggests that vitamin D may help in immunomodulation, regulating cell growth and 1,4 differentiation as well as some diverse unspecified functions. Overt vitamin D deficiency leads to hypocalcaemia, secondary hyperparathyroidism and increased bone turnover, which in prolonged and severe cases may cause rickets in children and osteomalacia in elderly.... JMS 2011;14(2):40-42


2020 ◽  
Author(s):  
Jagjit S Soar

he current COVID-19 pandemic now believed to be based on the mutation of the SARS-CoV virus (first reported in 2002) to SARS-CoV-2 emerging in 2019, is naturally causing extreme worry and concern around the world with sometimes mixed and incoherent messages on how to deal with it. There is a plethora of information from previous epidemics caused by other coronaviruses such as severe acute respiratory syndrome, SARS (2002) and Middle East respiratory syndrome MERS (2012) from which we can extrapolate guidance on how to deal with the current pandemic. In the current absence of specific pharmaceutical agents, we propose assessing the extended tools that we already possess in our biological armoury to combat, prevent and control the spread of this virus. Using a set of precise criteria to locate such possible contenders, we conducted literature searches to find compounds that met these criteria. We have now reduced this to a shortlist of three agents that may be the best candidates. We propose vitamin C, vitamin D and Curcumin fit our criteria well. These compounds are widely available to the general public. They are available online and over-the-counter as supplements. Otherwise healthy individuals are safely able to self-administer these agents as a prophylactic to protect themselves and to enhance their immune response. This would be especially desirable for the elderly and at risk groups. These agents can also be used as adjunct therapy, particularly for those who may have early symptoms. This preventative therapy could be implemented whilst awaiting specific pharmaceutical drugs to emerge as a treatment for COVID-19. Our suggested compounds are a highly cost-effective way to potentially reduce the mortality that is regretfully mounting as a result of COVID-19 infection. The biological mode of action and the dosing of these compounds are summarised.


2020 ◽  
Vol 58 (8) ◽  
pp. 1302-1313 ◽  
Author(s):  
Anwar Borai ◽  
Kiyoshi Ichihara ◽  
Abdulaziz Masaud ◽  
Waleed Tamimi ◽  
Suhad Bahijri ◽  
...  

AbstractBackgroundThis is a second part of report on the IFCC global multicenter study conducted in Saudi Arabia to derive reference intervals (RIs) for 20 immunoassay analytes including five tumor makers, five reproductive, seven other hormones and three vitamins.MethodsA total of 826 apparently healthy individuals aged ≥18 years were recruited in three clinical laboratories located in western, central and eastern Saudi Arabia using the protocol specified for the global study. All serum specimens were measured using Abbott, Architect analyzers. Multiple regression analysis (MRA) was performed to explore sources of variation of each analyte: age, body mass index (BMI), physical exercise and smoking. The magnitude of variation of reference values (RVs) attributable to sex, age and region was calculated by ANOVA as a standard deviation ratio (SDR). RIs were derived by the parametric (P) method.ResultsMRA revealed that region, smoking and exercise were not relevant sources of variation for any analyte. Based on SDR and actual between-sex differences in upper limits (ULs), we chose to partition RIs by sex for all analytes except for α-fetoprotein and parathyroid hormone (PTH). Age-specific RIs were required in females for ferritin, estradiol, progesterone, testosterone, follitropin, luteotropin and prolactin (PRL). With prominent BMI-related increase, RIs for insulin and C-peptide were derived after excluding individuals with BMI > 32 kg/m2. Individuals taking vitamin D supplements were excluded in deriving RIs for vitamin D and PTH.ConclusionsRIs of major immunoassay analytes specific for Saudi Arabians were established in careful consideration of various biological sources of variation.


2021 ◽  
Vol 49 ◽  
pp. 102760
Author(s):  
Steve Simpson-Yap ◽  
Pia Jelinek ◽  
Tracey Weiland ◽  
Nupur Nag ◽  
Sandra Neate ◽  
...  

2002 ◽  
pp. 45-59 ◽  
Author(s):  
K W Colston ◽  
C M√∏rk Hansen

It is now well established that, in addition to its central role in the maintenance of extracellular calcium levels and bone mineralization, 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)), the active form of vitamin D, also acts as a modulator of cell growth and differentiation in a number of cell types, including breast cancer cells. The anti-proliferative effects of 1,25(OH)(2)D(3) have been linked to suppression of growth stimulatory signals and potentiation of growth inhibitory signals, which lead to changes in cell cycle regulators such as p21(WAF-1/CIP1) and p27(kip1), cyclins and retinoblastoma protein as well as induction of apoptosis. Such studies have led to interest in the potential use of 1,25(OH)(2)D(3) in the treatment or prevention of certain cancers. Since this approach is limited by the tendency of 1,25(OH)(2)D(3) to cause hypercalcaemia, synthetic vitamin D analogues have been developed which display separation of the growth regulating effects from calcium mobilizing actions. This review examines mechanisms by which 1,25(OH)(2)D(3) and its active analogues exert both anti-proliferative and pro-apoptotic effects and describes some of the synthetic analogues that have been shown to be of particular interest in relation to breast cancer.


Sign in / Sign up

Export Citation Format

Share Document